Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Flow vs Low Flow Oxygen in Bronchiolitis
NCT03015051Phase 4Terminated
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxygen in bronchiolitis (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Hours of oxygen therapy up to 5 days. Started Jan 2017; status: terminated.
02
Drugs
oxygen
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT03015051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015051.